← The Wire
EWTXNasdaq
Edgewise Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1710072
Edgewise Therapeutics discovers and develops precision medicines targeting key muscle proteins for serious muscle diseases
⚡ Elevated coverage
$3.75B
Market cap
$40.92
Last close
-1.3%
1D
+12.1%
5D
1.9M
Volume
Price · last 39 sessions+30.1%
May 4L $31.43 · H $42.30Jun 29
107
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AApr 23, 2026DEF 14ADEF 14AApr 29, 2025DEF 14ADEF 14AApr 26, 2024DEF 14ADEF 14AApr 28, 2023DEF 14ADEF 14AMay 2, 2022
Insider Activity
In the 90 days to Mar 31, 2026: 2 sold $4.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Donovan Joanne M.CMO | Sell | 21,338 | $32.12 | $685K |
| Mar 27, 2026 | Donovan Joanne M.CMO | Sell | 9,623 | $30.98 | $298K |
| Mar 27, 2026 | Donovan Joanne M.CMO | Sell | 6,735 | $30.98 | $209K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 66,477 | $29.44 | $2.0M |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 17,236 | $29.44 | $507K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 13,690 | $29.44 | $403K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 10,463 | $29.44 | $308K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 7,605 | $29.44 | $224K |
| Nov 12, 2025 | Russell Alan JChief Scientific Officer | Sell | 100,000 | $21.12 | $2.1M |
| Nov 11, 2025 | Fox Jonathan CDirector | Buy | 10,700 | $18.64 | $199K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 2 reputable articles.
Investor's Business DailyBiotech Whips Violently Between Red And Green — What's Going On?14d agoInvestor's Business DailyHow Edgewise Sweetened Its Coffers By $1.55 Billion, And Removed A Key Overhang28d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance